stoxline Quote Chart Rank Option Currency Glossary
  
(SCG)
  0 (0%)    04-20 00:43
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2024-04-19 5:12:14 PM
Short term     
Mid term     
Targets 6-month :  20.67 1-year :  24.14
Resists First :  17.7 Second :  20.67
Pivot price 16.56
Supports First :  16.26 Second :  15.36
MAs MA(5) :  16.5 MA(20) :  16.57
MA(100) :  14.41 MA(250) :  10.98
MACD MACD :  0.2 Signal :  0.3
%K %D K(14,3) :  37.4 D(3) :  39.2
RSI RSI(14): 54.8
52-week High :  17.7 Low :  7.23
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ SGC ] has closed below upper band by 49.1%. Bollinger Bands are 31.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 16.71 - 16.77 16.77 - 16.82
Low: 16.17 - 16.25 16.25 - 16.31
Close: 16.46 - 16.58 16.58 - 16.68
Company Description

Headline News

Fri, 19 Apr 2024
Humphrey's high standards as Sun aims for SCG impact - Glen Innes Examiner

Fri, 19 Apr 2024
U.S. Fines Thai Company SCG Plastics $20 Million Over Alleged Iran Sanctions Violations - The Wall Street Journal

Fri, 19 Apr 2024
Thai plastics firm will pay $20 million to settle with U.S. over Iran sanctions violations - MSN

Fri, 19 Apr 2024
Unit Of Thailand's Scg Chemicals Pays $20 Mln To U.s. Over Appar… - Marketscreener.com

Fri, 19 Apr 2024
Avangrid Thanks Southern Connecticut Gas Employee for 51 Years of Service - Business Wire

Thu, 18 Apr 2024
SCG Cell Therapy and A*STAR Collaborate on Scalable GMP Manufacturing of Cellular Immunotherapies - Genetic Engineering & Biotechnology News

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 17 (M)
Shares Float 11 (M)
Held by Insiders 31.1 (%)
Held by Institutions 34.3 (%)
Shares Short 88 (K)
Shares Short P.Month 149 (K)
Stock Financials
EPS 0.54
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 11.93
Profit Margin 1.6 %
Operating Margin 4.5 %
Return on Assets (ttm) 2.7 %
Return on Equity (ttm) 4.5 %
Qtrly Rev. Growth -0.9 %
Gross Profit (p.s.) 0
Sales Per Share 32.51
EBITDA (p.s.) 2
Qtrly Earnings Growth 63.9 %
Operating Cash Flow 79 (M)
Levered Free Cash Flow 73 (M)
Stock Valuations
PE Ratio 30.7
PEG Ratio -2.2
Price to Book value 1.38
Price to Sales 0.5
Price to Cash Flow 3.51
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android